首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   602篇
  免费   116篇
  国内免费   2篇
  720篇
  2021年   6篇
  2019年   7篇
  2018年   10篇
  2017年   12篇
  2016年   11篇
  2015年   14篇
  2014年   21篇
  2013年   29篇
  2012年   34篇
  2011年   36篇
  2010年   22篇
  2009年   15篇
  2008年   22篇
  2007年   29篇
  2006年   25篇
  2005年   18篇
  2004年   27篇
  2003年   23篇
  2002年   19篇
  2001年   21篇
  2000年   22篇
  1999年   11篇
  1998年   21篇
  1997年   12篇
  1996年   11篇
  1995年   10篇
  1994年   12篇
  1993年   11篇
  1992年   17篇
  1991年   12篇
  1990年   11篇
  1989年   13篇
  1988年   16篇
  1987年   6篇
  1986年   9篇
  1985年   7篇
  1984年   7篇
  1983年   4篇
  1982年   8篇
  1976年   3篇
  1974年   7篇
  1972年   8篇
  1970年   4篇
  1969年   5篇
  1968年   3篇
  1967年   5篇
  1966年   4篇
  1965年   4篇
  1960年   3篇
  1943年   3篇
排序方式: 共有720条查询结果,搜索用时 0 毫秒
711.
712.
Short synthetic peptides homologous to the central region of Abeta but bearing proline residues as beta-sheet blockers have been shown in vitro to bind to Abeta with high affinity, partially inhibit Abeta fibrillogenesis, and redissolve preformed fibrils. While short peptides have been used extensively as therapeutic drugs in medicine, two important problems associated with their use in central nervous system diseases have to be addressed: (a) rapid proteolytic degradation in plasma, and (b) poor blood-brain barrier (BBB) permeability. Recently, we have demonstrated that the covalent modification of proteins with the naturally occurring polyamines significantly increases their permeability at the BBB. We have extended this technology to iAbeta11, an 11-residue beta-sheet breaker peptide that inhibits Abeta fibrillogenesis, by covalently modifying this peptide with the polyamine, putrescine (PUT), and evaluating its plasma pharmacokinetics and BBB permeability. After a single intravenous bolus injection in rats, both 125I-YiAbeta11 and 125I-PUT-YiAbeta11 showed rapid degradation in plasma as determined by trichloroacetic acid (TCA) precipitation and paper chromatography. By switching to the all D-enantiomers of YiAbeta11 and PUT-YiAbeta11, significant protection from degradation by proteases in rat plasma was obtained with only 1.9% and 5.7% degradation at 15 min after intravenous bolus injection, respectively. The permeability coefficient x surface area product at the BBB was five- sevenfold higher in the cortex and hippocampus for the 125I-PUT-D-YiAbeta11 compared to the 125I-D-YiAbeta11, with no significant difference in the residual plasma volume. In vitro assays showed that PUT-D-YiAbeta11 retains its ability to partially inhibit Abeta fibrillogenesis and dissolve preformed amyloid fibrils. Because of its five- to sevenfold increase in permeability at the BBB and its resistance to proteolysis in the plasma, this polyamine-modified beta-sheet breaker peptide may prove to be an effective inhibitor of amyloidogenesis in vivo and, hence, an important therapy for Alzheimer's disease.  相似文献   
713.
The return of salmon in 1978 to the River Gryfe, a tributary of the Clyde estuary, and to the River Clyde itself in 1983, provides the opportunity for the derivation of the threshold oxygen requirements within the estuary for the successful migration of both adults and smolts.  相似文献   
714.
Bioactive compounds produced by cyanobacteria   总被引:7,自引:0,他引:7  
Cyanobacteria produce a large number of compounds with varying bioactivities. Prominent among these are toxins: hepatotoxins such as microcystins and nodularins and neurotoxins such as anatoxins and saxitoxins. Cytotoxicity to tumor cells has been demonstrated for other cyanobacterial products, including 9-deazaadenosine, dolastatin 13 and analogs. A number of compounds in cyanobacteria are inhibitors of proteases — micropeptins, cyanopeptolins, oscillapeptin, microviridin, aeruginosins- and other enzymes, while still other compounds have no recognized biological activities. In general cyclic peptides and depsipeptides are the most common structural types, but a wide variety of other types are also found: linear peptides, guanidines, phosphonates, purines and macrolides. The close similarity or identity in structures between cyanobacterial products and compounds isolated from sponges, tunicates and other marine invertebrates suggests the latter compounds may be derived from dietary or symbiotic blue-green algae.  相似文献   
715.
716.
717.
718.
J Curran  D Kolakofsky 《Enzyme》1990,44(1-4):244-249
The Sendai virus P gene contains overlapping open reading frames (ORFs), and several unusual mechanisms are used to produce multiple proteins from all three ORFs of this gene. These include the use of a non-AUG start codon, leaky ribosomal scanning, what appears to be scanning-independent ribosomal initiation and/or ribosomal jumping, and a form of mRNA editing.  相似文献   
719.
The present experiments were undertaken to elucidate the effect of either the hepatocyte (HC) or hepatocyte supernatant on prelabeled endotoxin (LPS)-stimulated Kupffer cell (KC) arachidonic acid utilization. HC, KC, or their coculture were incubated for 18 hours with labeled 1-14C- arachidonic acid followed by a 24 hour incubation with 10 micrograms/ml LPS. LPS had no effect on the percent distribution of labeled arachidonate into the HC phospholipid or neutral lipid. KC showed a decreased percent neutral lipid labeled arachidonic acid distribution with generally no effect on the phospholipid. However, KC:HC cocultures or the addition of HC supernatant to KC exposed to LPS dramatically reversed the labeled arachidonate distribution into the KC with an increased incorporation into neutral lipid. Labeled PGE2 and PGD2 were increased in the KC following incubation with HC supernatant while only labeled PGE2 levels were elevated in the cocultures. The changes in the distribution of cell's labeled arachidonate required the addition of LPS. These results suggest that the HC can promote changes in the lipid fraction during sepsis by elaborating a substance that can modulate labeled arachidonate distribution in the KC lipids as well as stimulate prostaglandin production.  相似文献   
720.
As part of a comprehensive research program on Life Cycle Assessment (LCA) methodology and practices, the US Environmental Protection Agency (EPA) hosted a meeting in Cincinnati, Ohio, on June 12 & 13, 1995, on Streamlining LCA. Organized by Research Triangle Institute’s Center for Environmental Analysis for the EPA, the conference provided a forum where practitioners and researchers could present the most up-to-date information on streamlined approaches. Time was also allotted for facilitated discussion which allowed the participants to express their thoughts and experiences with streamlined LCA applications, leading to butter understanding of the subject.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号